LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAD0. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $36,575,000 | -0.0% | 20,000,000 | 0.0% | 0.65% | +19.0% |
| Q3 2017 | $36,588,000 | -19.7% | 20,000,000 | -27.3% | 0.55% | -19.4% |
| Q2 2017 | $45,566,000 | +22.2% | 27,500,000 | +10.0% | 0.68% | +25.7% |
| Q1 2017 | $37,301,000 | +3.1% | 25,000,000 | 0.0% | 0.54% | -16.0% |
| Q4 2016 | $36,172,000 | -1.2% | 25,000,000 | 0.0% | 0.64% | +11.2% |
| Q3 2016 | $36,611,000 | +119.2% | 25,000,000 | +150.0% | 0.58% | +112.9% |
| Q2 2016 | $16,703,000 | +55.7% | 10,000,000 | +21.2% | 0.27% | +63.9% |
| Q3 2015 | $10,730,000 | – | 8,250,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mint Tower Capital Management B.V. | 10,000,000 | $14,917,000 | 3.39% |
| Opera Trading Capital | 5,700,000 | $8,490,000 | 2.38% |
| TFG Asset Management GP Ltd | 8,100,000 | $12,093,000 | 2.27% |
| CQS Cayman LP | 18,000,000 | $26,872,000 | 2.04% |
| BASSO CAPITAL MANAGEMENT, L.P. | 6,470,000 | $9,632,000 | 1.43% |
| Myriad Asset Management Ltd. | 9,416,000 | $14,061,000 | 1.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 22,025,000 | $32,817,000 | 0.85% |
| ANGELO GORDON & CO., L.P. | 7,000,000 | $10,430,000 | 0.64% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 25,000,000 | $37,301,000 | 0.54% |
| CSS LLC/IL | 5,105,000 | $7,617,000 | 0.46% |